Tag: edoxaban

ESC 2026: edoxaban fails to reduce stroke or systemic embolism in...

Edoxaban—an oral anticoagulant medication—failed to reduce stroke or systemic embolism but did increase major bleeding in high-risk patients with atrial fibrillation (AF) who had...